they are not dead money. they are more live than PACB. Their internal valuation is 3X PACB, and just raised more money. As long as their "vaporware" story attracts interest, PACB is dead money, dead money in real. Who will pay 700K to buy a pacbio instrument while the cheap vaporware can replace it with a lot less money, space and maintenance requirement?
Now PacBio needs to prove they are better than the vaporware, not the otherway around? PACB is on the losing track, can you see it from the recent stock price trend?
Your argument also backfired on PacBio. If Pacbio is that good like you have believed, why Life, illumina never wanted it. Roche is the biggest joke. They bought 454, and what happened. Their business vision is very blurred.
hahaha, nanopore has never shown any kind of data except for some "squiggles" on a computer screen. I'm glad to see the nanopore drama is unfolding faster. without surprise, I would predict they will announce the delay of the so called Early access program for "technical reason" later this month.
Can you predict how many machines will PacBio sell for this quarter? We are all trying to make money betting on stocks. Nothing else matters. I will buy PacBio if they show any promise of turning the business around. I bought and cashed out after the Roche news. I hope they have something like that up the sleeves. But I don't see any signs yet.